Literature DB >> 1681159

Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum.

P Rutgeerts1, K Goboes, M Peeters, M Hiele, F Penninckx, R Aerts, R Kerremans, G Vantrappen.   

Abstract

Aphthous lesions recur in the neoterminal ileum within the first few months after curative resection of the distal ileum in patients with Crohn's disease. These lesions do not originate from microscopic disease that is already present at the time of surgery. To investigate the importance of faecal stream in the pathogenesis of recurrent Crohn's lesions, we have studied 5 patients with Crohn's disease who had ileal resection. After curative resection and ileocolonic anastomosis, a diverting terminal ileostomy was constructed 25-35 cm proximal to the anastomosis thereby excluding the neoterminal ileum, the anastomosis, and the colon from intestinal transit. After six months of exclusion, endoscopy of the ileocolon was undertaken and biopsy specimens were taken. Transit was then restored. Six months after reanastomosis further biopsy specimens were taken. These patients were compared with a control group of 75 patients with Crohn's disease who underwent a one-step ileal resection and ileocolonic anastomosis. None of the 5 patients had endoscopic lesions in the neoterminal ileum after six months of exclusion and biopsies did not show inflammatory changes characteristic of Crohn's disease. By contrast, 53 of 75 patients with one-step surgery had endoscopic recurrence in the neoterminal ileum within six months of surgery. All 5 patients had an important recurrence of disease, both endoscopically and histologically, at ileocolonoscopy six months after reanastomosis. Our findings strongly support the view that recurrence of Crohn's disease in the neoterminal ileum after curative ileal resection is dependent on faecal stream.

Entities:  

Mesh:

Year:  1991        PMID: 1681159     DOI: 10.1016/0140-6736(91)90663-a

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  201 in total

Review 1.  Anti-TNF antibody treatment of Crohn's disease.

Authors:  S J van Deventer
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  Intestinal stasis associated bowel inflammation.

Authors:  Shunichiro Komatsu; Yuji Nimura; D Neil Granger
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

Review 3.  Medical management of postoperative complications of inflammatory bowel disease: pouchitis and Crohn's disease recurrence.

Authors:  J P Achkar; B Shen
Journal:  Curr Gastroenterol Rep       Date:  2001-12

Review 4.  Future therapies for inflammatory bowel disease.

Authors:  Stephen J Bickston; Lawrence W Comerford; Fabio Cominelli
Journal:  Curr Gastroenterol Rep       Date:  2003-12

5.  Regression of Peyer's patches in G alpha i2 deficient mice prior to colitis is associated with reduced expression of Bcl-2 and increased apoptosis.

Authors:  L Ohman; L Franzén; U Rudolph; L Birnbaumer; E Hultgren Hörnquist
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

Review 6.  Crohn disease: a current perspective on genetics, autophagy and immunity.

Authors:  Thaddeus S Stappenbeck; John D Rioux; Atsushi Mizoguchi; Tatsuya Saitoh; Alan Huett; Arlette Darfeuille-Michaud; Tom Wileman; Noboru Mizushima; Simon Carding; Shizuo Akira; Miles Parkes; Ramnik J Xavier
Journal:  Autophagy       Date:  2011-04-01       Impact factor: 16.016

Review 7.  Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases.

Authors:  Fernando Ochoa-Cortes; Fabio Turco; Andromeda Linan-Rico; Suren Soghomonyan; Emmett Whitaker; Sven Wehner; Rosario Cuomo; Fievos L Christofi
Journal:  Inflamm Bowel Dis       Date:  2016-02       Impact factor: 5.325

8.  Effects of trefoil peptide 3 on expression of TNF-alpha, TLR4, and NF-kappaB in trinitrobenzene sulphonic acid induced colitis mice.

Authors:  Xu Teng; Ling-Fen Xu; Ping Zhou; Hong-Wei Sun; Mei Sun
Journal:  Inflammation       Date:  2009-04       Impact factor: 4.092

9.  Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease.

Authors:  S J Ott; M Musfeldt; D F Wenderoth; J Hampe; O Brant; U R Fölsch; K N Timmis; S Schreiber
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

10.  Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG.

Authors:  C Prantera; M L Scribano; G Falasco; A Andreoli; C Luzi
Journal:  Gut       Date:  2002-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.